docetaxel anhydrous has been researched along with Sensitivity and Specificity in 89 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (6.74) | 18.2507 |
| 2000's | 45 (50.56) | 29.6817 |
| 2010's | 36 (40.45) | 24.3611 |
| 2020's | 2 (2.25) | 2.80 |
| Authors | Studies |
|---|---|
| Du, Q; Li, W; Li, X; Liu, S; Pan, F; Xi, X; Yang, J | 1 |
| Bektasoglu, HK; Erdogan, EB; Ersoy, YE; Gucin, Z; Guzel, M; Kadioglu, H; Malya, FU; Yildiz, S; Yucel, S | 1 |
| Aa, J; Feng, D; Feng, S; Gao, H; Gu, H; Peng, Y; Sun, R; Wang, G; Wang, Y; Yang, N; Zhang, J; Zhang, Y; Zhou, F | 1 |
| Ding, F; Hao, K; Jiang, W; Li, P; Lu, L; Pei, X; Sun, Y; Wang, G | 1 |
| Dutta, S; Halabi, S; Kelly, WK; Morris, MJ; Russell, C; Ryan, CJ; Small, EJ; Taplin, ME | 1 |
| Cao, F; Chen, X; Cheng, J; Er, P; Guan, Y; Jiang, H; Li, X; Pang, Q; Qian, D; Wang, J; Wang, P; Wang, Y; Yu, Z; Yuan, Z; Zhang, B; Zhang, W; Zhao, G; Zhou, D | 1 |
| Barbas, C; Calvo, E; Durán, I; García, A; Martínez-Alcázar, MP; Navarrete, A; Valenzuela, B | 1 |
| Beijnen, JH; Cirkel, GA; Hillebrand, MJ; Kort, A; Rosing, H; Schellens, JH; Schinkel, AH; Voest, EE | 1 |
| Ji, M; Jiang, JT; Li, XD; Wu, CP; Wu, J; Xu, B; Zhang, HY; Zhao, WQ; Zhou, WJ | 1 |
| Heidenreich, A; Pfister, D; Porres, D | 1 |
| Armstrong, AJ; de Bono, J; Halabi, S; Kaplan, EB; Lin, CY; Oudard, S; Petrylak, D; Sartor, O; Shen, L; Small, EJ; Sternberg, CN | 1 |
| Basset, V; Crouzet, S; Flamand, V; Ploussard, G | 1 |
| Chen, W; Feng, J; Gao, S; Miao, H; Tao, X; Yun, Y; Zhang, F; Zhou, J | 1 |
| Charles-Edwards, G; Ganeshan, B; Glendenning, J; Goh, V; Harries, M; Mansi, J; Parikh, J; Selmi, M; Tutt, A; Verma, H | 1 |
| Kobayashi, M; Komatsu, K; Kubo, T; Kurokawa, S; Morita, T; Nakano, K; Natsui, S; Nukui, A | 1 |
| Kim, K; Kim, SY; Kwon, IC; Lee, DE; Oh, KS; Seo, JH; Yhee, JY; Yuk, SH | 1 |
| Du, P; Han, X; Li, N; Shi, Y; Song, Y; Wang, H; Yang, S | 1 |
| Cho, H; Kim, JH; Kim, S; Kim, SW; Kim, YT; Lee, M; Nam, EJ | 1 |
| Hara, H; Itaya, N; Nutahara, K; Okegawa, T; Tambo, M | 1 |
| Gao, D; Gao, L; Jia, B; Liu, Z; Sun, X; Wang, F; Yu, X; Zhang, C | 1 |
| Dank, M; Györke, T; Kajáry, K; Kulka, J; Lengyel, Z; Molnár, BÁ; Szentmártoni, G; Tőkés, AM; Tőkés, T; Torgyík, L | 1 |
| Fujino, Y; Goji, T; Kimura, T; Kitamura, S; Miyamoto, H; Miyoshi, J; Muguruma, N; Okahisa, T; Okamoto, K; Sogabe, M; Takayama, T; Taniguchi, T; Tomonari, T | 1 |
| Bellersen, L; Bulten, BF; de Geus-Oei, LF; Joosten, LA; Kapusta, L; Mandigers, CM; Mavinkurve-Groothuis, AM; van Boxtel, W; van Laarhoven, HW | 1 |
| Choi, SH; Kim, JH; Kim, SC; Ryoo, I; Sohn, CH | 1 |
| Guo, H; Lan, Z; Liu, Z; Wang, J; Yu, Y; Zhang, L | 1 |
| Fu, YJ; Hua, X; Jiang, SG; Wang, JT; Wang, Z; Zhang, L; Zhang, Y; Zu, YG | 1 |
| Haid, A; Konstantiniuk, P; Kugler, F; Pöstlberger, S; Reitsamer, R; Roka, S; Tausch, C | 1 |
| Boehm, A; Dietz, A; Dollner, R; Horn, IS; Mozet, C; Tschop, K; Wichmann, G | 1 |
| Doral Stefani, S; Giorgio Saggia, M; Vicino dos Santos, EA | 1 |
| Puglisi, F | 1 |
| Bermingham, S; McMahon, GP; O'Connor, R; Regan, F | 1 |
| Gu, Z; Shen, Y; Wang, M; Xu, Q; Xu, S; Yin, X; Zhang, L; Zhang, N | 1 |
| Ahn, S; Dalton, JT; Li, CM; Lu, Y; Miller, DD; Narayanan, R | 1 |
| Ahmed, FJ; Diwan, PV; Parikh, N; Sistla, R; Venishetty, VK | 1 |
| Fujiwara, H; Furutani, A; Ichikawa, D; Ikoma, H; Kokuba, Y; Komatsu, S; Kuriu, Y; Nakanishi, M; Ochiai, T; Okamoto, K; Okamura, H; Okamura, S; Otsuji, E; Shiozaki, A; Sonoyama, T; Todo, M; Umehara, S; Yoneda, M | 1 |
| Dai, Y; Fan, CY; Neis, JP; Spring, PM; Vural, E; Xie, CH | 1 |
| Hashimoto, S; Hirai, Y; Kawago, M; Naito, K; Nakamura, R; Nishiguchi, H; Ohta, F; Okamura, Y; Oura, S; Yoshimasu, T | 1 |
| Beijnen, JH; Hendrikx, JJ; Hillebrand, MJ; Rosing, H; Schellens, JH; Schinkel, AH; Thijssen, B | 1 |
| Gorlia, T; Liberato, NL; Licitra, L; Marchetti, M; Quaglini, S; Rognoni, C; Rubrichi, S; Vermorken, JB | 1 |
| Fujikawa, A; Furugen, A; Iseki, K; Ito, H; Kobayashi, M; Mano, N; Miyamori, K; Ogura, J; Takahashi, N; Tanaka, N; Yamada, T; Yamaguchi, H | 1 |
| Kim, IS; Kim, TK; Yoo, HH | 1 |
| Bennett, HL; Fleming, JT; Leung, HY; Mandal, R; O'Prey, J; Robson, CN; Ryan, KM; Stockley, J | 1 |
| Krause, BJ; Nawroth, R; Sachs, D; Schuster, T; Schwaiger, M; Schwarzenböck, S; Senekowitsch-Schmidtke, R; Souvatzoglou, M; Treiber, U; Weirich, G; Wester, HJ; Ziegler, S | 1 |
| Bachmann, N; Barberi-Heyob, M; Merlin, JL | 1 |
| Ackland, SP; Clarke, S; Garg, MB; Millward, MJ; Rischin, D; Smith, J; Toner, GC; Zalcberg, J | 1 |
| Egorin, MJ; Parise, RA; Ramanathan, RK; Zamboni, WC | 1 |
| Hudis, C | 1 |
| Bernard-Marty, C; Bissery, MC; Cardoso, F; Di Leo, A; Dumontet, C; Fellous, A; Gancberg, D; Larsimont, D; Paesmans, M; Piccart, MJ; Treilleux, I | 1 |
| Mohamed, F; Sugarbaker, PH | 1 |
| Baker, SD; Carducci, MA; He, P; Sparreboom, A; Verweij, J; Zhao, M | 1 |
| Hou, W; McLeod, HL; Watters, JW | 1 |
| Cao, Q; Choy, H; Kim, JC; Saha, D | 1 |
| Lambert, WE; Mortier, KA; Verstraete, AG; Zhang, GF | 1 |
| Devries, A; Haidenberger, A; Lukas, P; Nevinny-Stickel, M; Saurer, M; Seppi, T; Skvortsov, S; Skvortsova, I | 1 |
| Bukowski, RM; Ganapathi, R; Grozav, AG; Hutson, TE; Xu, Y; Zhou, X | 1 |
| Ajani, JA; Bresalier, R; Correa, AM; Erasmus, JJ; Komaki, R; Macapinlac, H; Maish, M; Munden, RF; Putnam, JB; Rice, D; Roth, JA; Smythe, WR; Swisher, SG; Vaporciyan, AA; Walsh, GL; Wu, TT | 1 |
| Beijnen, JH; Kuppens, IE; Rosing, H; Schellens, JH; van Maanen, MJ | 1 |
| El-Sheemy, M; Eremin, J; Eremin, O; Griffiths, PA; Marshall, C | 1 |
| Gao, S; Iyer, SS; Karnes, HT; Kellogg, GE; Zhang, ZP | 1 |
| Hornberger, J; Jamieson, C; Jones, S; Maraninchi, D; Martín, M; McKendrick, J; Miles, D; O'Shaughnessy, J; Twelves, C; Verma, S | 1 |
| Bosch, CA; Hannemann, J; Loo, C; Oosterkamp, HM; Rodenhuis, S; Rutgers, EJ; van de Vijver, MJ; Velds, A; Wessels, LF | 1 |
| Bartz, B; Carson, PL; Fowlkes, JB; Gordon, SP; Johnson, TD; LeCarpentier, GL; Pai, D; Roubidoux, MA; Schott, AF | 1 |
| Lambert, WE; Mortier, KA; Renard, V; Van Belle, S; Van Gussem, A; Verstraete, AG | 1 |
| Cohen, S; Droz, JP; Freyer, G; Guillaumont, M; Guitton, J; Manchon, M; Tranchand, B; Vignal, B | 1 |
| Baker, LH; Griffith, KA; Hayes, DF; Helvie, MA; Hunt, KA; Kleer, CG; Murray, S; Newman, LA; Paramagul, C; Pierce, LJ; Roubidoux, MA; Schott, AF | 1 |
| Edinboro, LE; Gao, S; Karnes, HT; Ngoka, LC; Zhang, ZP | 1 |
| Aamdal, S; Andersen, A; Brunsvig, PF; Kristensen, GB; Olsen, H; Warren, DJ | 1 |
| Benner, A; Brors, B; Eils, R; Hahn, M; Kramer, H; Lichter, P; Rudlowski, C; Schneeweiss, A; Schuetz, F; Sinn, HP; Sohn, C; Tews, B; Thuerigen, O; Toedt, G; Warnat, P | 1 |
| Agrawal, S; Cherton-Horvat, GG; Durkin, JP; Gillard, JW; Hewitt, KE; Jerome, LJ; Kandimalla, ER; LaCasse, EC; Morris, SJ; Wang, H; Wang, W; Yu, D; Zhang, R | 1 |
| Aubert, G; Chiaroni, A; Dubois, J; Guénard, D; Guéritte, F; Larroque, AL; Thoret, S | 1 |
| Arslan, M; Demiray, M; Ercan, I; Evrensel, T; Gokgoz, S; Manavoglu, O; Saraydaroglu, O; Ulukaya, EE | 1 |
| d'Amato, TA; Huang, W; Landreneau, RJ; Luketich, JD; Mechetner, E; Parker, R; Ricketts, W; Yu, IR | 1 |
| Ayla, S; Bilir, A; Goksel, G; Oktem, G; Saydam, G; Uysal, A; Yavasoglu, A | 1 |
| Hanna, WT; Hubner, KF; Long, MJ; Nahmias, C; Townsend, DW; Wahl, LM | 1 |
| Acharya, CR; André, S; Becette, V; Bergh, J; Blot, E; Bonnefoi, H; Cameron, D; Campone, M; Delorenzi, M; Farmer, P; Iggo, RD; Jassem, J; Mauriac, L; Mukherjee, S; Nevins, JR; Petit, T; Potti, A; Rouanet, P; Tubiana-Hulin, M | 1 |
| Bleiweiss, IJ; Raptis, G | 1 |
| Andreetta, C; Cardellino, GG; Crivellari, D; Damante, G; Di Loreto, C; Lombardi, D; Magri, MD; Mansutti, M; Minisini, AM; Perin, T; Puglisi, F; Russo, S; Veronesi, A | 1 |
| Bissery, MC; Chabot, GG; Lavelle, F; Vrignaud, P | 1 |
| Blaschke, G; Boos, J; Hempel, G; Krümpelmann, S; Lehmkuhl, D | 1 |
| Loos, WJ; Nooter, K; Sparreboom, A; Stoter, G; Verweij, J | 2 |
| Bonneterre, J; Launois, RJ; Reboul-Marty, JM | 1 |
| Ardizzoni, A; de Cupis, A; Favoni, RE; Grossi, F; Loprevite, M; Merlo, F; Pirani, P | 1 |
| Ah-See, AK; Chilcott, F; Eremin, O; Gilbert, FJ; Heys, SD; Hutcheon, AW; Miller, ID; Payne, S; Sharp, PF; Smith, IC; Waikar, S; Welch, AE; Whitaker, T | 1 |
| Blachon, MF; Catalin, J; Ciccolini, J; Durand, A | 1 |
| Kobina, S; Moyano, A; Rubio-Terrés, C; Tisaire, JL | 1 |
| Clegg, A; Hewitson, P; Scott, DA; Sidhu, M; Waugh, N | 1 |
| Burkes, RL; Feld, R; Goodwin, PJ; Kwong, R; Leighl, NB; Shepherd, FA | 1 |
| Baker, SD; Brahmer, JR; Sparreboom, A; Verweij, J; Zhao, M | 1 |
7 review(s) available for docetaxel anhydrous and Sensitivity and Specificity
| Article | Year |
|---|---|
[Biomarker docetaxel-based chemotherapy].
Topics: Antineoplastic Agents; Biomarkers, Tumor; Docetaxel; Evidence-Based Medicine; Humans; Male; Neoplasm Proteins; Prevalence; Prognosis; Prostatic Neoplasms; Reproducibility of Results; Risk Factors; Sensitivity and Specificity; Taxoids | 2013 |
[Choice of new drugs in castration-resistant prostate cancer: predictive factors and effectiveness assessment].
Topics: Androstenes; Androstenols; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Docetaxel; Drug Resistance, Neoplasm; Evidence-Based Medicine; Humans; Male; Predictive Value of Tests; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Risk Factors; Sensitivity and Specificity; Taxoids; Treatment Outcome | 2013 |
Adjuvant use of taxanes for patients with breast cancer: we see the tip of the iceberg.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Breast Neoplasms; Chemotherapy, Adjuvant; Clinical Trials, Phase III as Topic; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Mastectomy, Segmental; Neoplasm Staging; Paclitaxel; Patient Selection; Prognosis; Randomized Controlled Trials as Topic; Sensitivity and Specificity; Survival Analysis; Taxoids; Treatment Outcome; United States | 2002 |
Intraperitoneal taxanes.
Topics: Antineoplastic Agents, Phytogenic; Biological Availability; Chemotherapy, Adjuvant; Clinical Trials, Phase II as Topic; Docetaxel; Dose-Response Relationship, Drug; Female; Gastrointestinal Neoplasms; Humans; Infusions, Parenteral; Male; Maximum Tolerated Dose; Paclitaxel; Risk Assessment; Sensitivity and Specificity; Taxoids | 2003 |
Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Docetaxel; Endosonography; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Irinotecan; Life Tables; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Positron-Emission Tomography; Preoperative Care; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Radiotherapy, Adjuvant; Retrospective Studies; Sensitivity and Specificity; Survival Analysis; Taxoids; Tomography, X-Ray Computed; Treatment Outcome | 2004 |
[A medico-economic evaluation of second line chemotherapy in metastatic breast cancer: comparison between docetaxel, paclitaxel, and vinorelbine].
Topics: Aged; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cost-Benefit Analysis; Docetaxel; Drug Administration Schedule; Female; Humans; Neoplasm Metastasis; Paclitaxel; Quality of Life; Sensitivity and Specificity; Survival Analysis; Taxoids; Treatment Outcome; Vinblastine; Vinorelbine | 1997 |
Clinical and cost effectiveness of paclitaxel, docetaxel, gemcitabine, and vinorelbine in non-small cell lung cancer: a systematic review.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cost of Illness; Cost-Benefit Analysis; Deoxycytidine; Docetaxel; Gemcitabine; Humans; Lung Neoplasms; Paclitaxel; Quality of Life; Randomized Controlled Trials as Topic; Sensitivity and Specificity; Taxoids; Treatment Outcome; Vinblastine; Vinorelbine | 2002 |
14 trial(s) available for docetaxel anhydrous and Sensitivity and Specificity
| Article | Year |
|---|---|
Tumor Remission and Tumor-Infiltrating Lymphocytes During Chemoradiation Therapy: Predictive and Prognostic Markers in Locally Advanced Esophageal Squamous Cell Carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Docetaxel; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Female; Humans; Lymphocytes, Tumor-Infiltrating; Male; Middle Aged; Preoperative Period; Prognosis; Prospective Studies; Radiotherapy, Intensity-Modulated; Remission Induction; ROC Curve; Sensitivity and Specificity; Survival Analysis; Treatment Outcome | 2019 |
Relationship between glutathione S-transferase P1 (GSTP1), X-ray repair cross complementing group 1 (XRCC1) and 5,10-methylenetetrahydrofolate reductase (5,10-MTHFR) gene polymorphisms and response to chemotherapy in advanced gastric cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; China; Cisplatin; DNA-Binding Proteins; Docetaxel; Female; Fluorouracil; Genetic Markers; Glutathione S-Transferase pi; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Outcome Assessment, Health Care; Polymorphism, Single Nucleotide; Prevalence; Prognosis; Reproducibility of Results; Risk Factors; Sensitivity and Specificity; Stomach Neoplasms; Survival Analysis; Survival Rate; Taxoids; Treatment Outcome; X-ray Repair Cross Complementing Protein 1 | 2013 |
Prognostic model predicting metastatic castration-resistant prostate cancer survival in men treated with second-line chemotherapy.
Topics: Aged; Alkaline Phosphatase; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Biomarkers, Tumor; Docetaxel; Drug Administration Schedule; Hemoglobins; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Mitoxantrone; Models, Statistical; Multivariate Analysis; Nomograms; Organoplatinum Compounds; Pain; Predictive Value of Tests; Prednisone; Prognosis; Proportional Hazards Models; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Sensitivity and Specificity; Taxoids; Treatment Outcome | 2013 |
External validation of risk classification in patients with docetaxel-treated castration-resistant prostate cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Biomarkers, Tumor; Docetaxel; Humans; Male; Middle Aged; Prognosis; Proportional Hazards Models; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Taxoids; Treatment Outcome | 2014 |
Single tissue samples from head and neck squamous cell carcinomas are representative regarding the entire tumor's chemosensitivity to cisplatin and docetaxel.
Topics: Adult; Aged; Antineoplastic Agents; Biopsy; Carcinoma, Squamous Cell; Cisplatin; Docetaxel; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Reproducibility of Results; Sensitivity and Specificity; Taxoids; Treatment Outcome | 2009 |
Phase I and pharmacokinetic study of docetaxel in combination with epirubicin and cyclophosphamide in advanced cancer: dose escalation possible with granulocyte colony-stimulating factor, but not with prophylactic antibiotics.
Topics: Adult; Aged; Antibiotic Prophylaxis; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Confidence Intervals; Cyclophosphamide; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Epirubicin; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Staging; Neoplasms; Paclitaxel; Probability; Risk Assessment; Sensitivity and Specificity; Survival Rate; Taxoids; Treatment Outcome | 2002 |
Monitoring the response of large (>3 cm) and locally advanced (T3-4, N0-2) breast cancer to neoadjuvant chemotherapy using (99m)Tc-Sestamibi uptake.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Docetaxel; Doxorubicin; Female; Humans; Image Interpretation, Computer-Assisted; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Severity of Illness Index; Taxoids; Technetium Tc 99m Sestamibi; Treatment Outcome | 2005 |
Capecitabine plus docetaxel combination therapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Combined Modality Therapy; Cost-Benefit Analysis; Deoxycytidine; Docetaxel; Female; Fluorouracil; Humans; Middle Aged; Prospective Studies; Quality of Life; Sensitivity and Specificity; Survival Rate; Taxoids; Treatment Outcome | 2005 |
Changes in gene expression associated with response to neoadjuvant chemotherapy in breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Docetaxel; Doxorubicin; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genetic Markers; Humans; Middle Aged; Multigene Family; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Staging; Prognosis; Risk Assessment; RNA, Neoplasm; Sensitivity and Specificity; Survival Analysis; Taxoids; Treatment Outcome | 2005 |
Sonographic evaluation of early-stage breast cancers that undergo neoadjuvant chemotherapy.
Topics: Adult; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Docetaxel; Doxorubicin; Female; Humans; Image Processing, Computer-Assisted; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Neoplasm, Residual; Predictive Value of Tests; Prospective Studies; Reproducibility of Results; Sensitivity and Specificity; Taxoids; Ultrasonography, Doppler, Color; Ultrasonography, Mammary | 2005 |
Time course of early response to chemotherapy in non-small cell lung cancer patients with 18F-FDG PET/CT.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Carboplatin; Carcinoma, Non-Small-Cell Lung; Docetaxel; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Taxoids; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
Validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Docetaxel; Epirubicin; Female; Fluorouracil; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genetic Testing; Humans; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Oligonucleotide Array Sequence Analysis; Patient Selection; Predictive Value of Tests; Receptors, Estrogen; Reproducibility of Results; ROC Curve; Sensitivity and Specificity; Taxoids; Treatment Outcome | 2007 |
Thymidine phosphorylase expression is associated with time to progression in patients receiving low-dose, docetaxel-modulated capecitabine for metastatic breast cancer.
Topics: Administration, Oral; Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Capecitabine; Carcinoma, Ductal; Carcinoma, Lobular; Deoxycytidine; Disease Progression; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Synergism; Female; Fluorouracil; Gastrointestinal Diseases; Hematologic Diseases; Humans; Infusions, Intravenous; Liver Neoplasms; Maximum Tolerated Dose; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Prognosis; Risk Assessment; Sensitivity and Specificity; Survival Analysis; Taxoids; Thymidine Phosphorylase; Treatment Outcome; Up-Regulation | 2008 |
Sensitive determination of docetaxel in human plasma by liquid-liquid extraction and reversed-phase high-performance liquid chromatography.
Topics: Aged; Antineoplastic Agents, Phytogenic; Chromatography, High Pressure Liquid; Docetaxel; Female; Humans; Neoplasms; Paclitaxel; Reproducibility of Results; Sensitivity and Specificity; Taxoids | 1997 |
68 other study(ies) available for docetaxel anhydrous and Sensitivity and Specificity
| Article | Year |
|---|---|
An improved LC-MS/MS method for determination of docetaxel and its application to population pharmacokinetic study in Chinese cancer patients.
Topics: Adult; Antineoplastic Agents; China; Chromatography, Liquid; Docetaxel; Humans; Linear Models; Neoplasms; Reproducibility of Results; Sensitivity and Specificity; Solid Phase Extraction; Tandem Mass Spectrometry; Young Adult | 2020 |
The role of PET and MRI in evaluating the feasibility of skin-sparing mastectomy following neoadjuvant therapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Breast Neoplasms; Cyclophosphamide; Docetaxel; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Mastectomy; Middle Aged; Minimally Invasive Surgical Procedures; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Taxoids | 2018 |
Application of liquid chromatography-tandem mass spectrometry to study the effect of docetaxel on pharmacokinetics and tissue distribution of apatinib in mice.
Topics: Animals; Chromatography, Liquid; Docetaxel; Linear Models; Male; Mice; Mice, Inbred BALB C; Pyridines; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry; Taxoids; Tissue Distribution | 2018 |
A robust LC-MS/MS method for the simultaneous determination of docetaxel and voriconazole in rat plasma and its application to pharmacokinetic studies.
Topics: Animals; Chromatography, Liquid; Docetaxel; Drug Stability; Linear Models; Liquid-Liquid Extraction; Male; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry; Taxoids; Voriconazole | 2018 |
Androgen decline and survival during docetaxel therapy in metastatic castration resistant prostate cancer (mCRPC).
Topics: Androgens; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Docetaxel; Humans; Male; Neoplasm Metastasis; Neoplasm Staging; Prostatic Neoplasms, Castration-Resistant; Sensitivity and Specificity; Treatment Outcome | 2020 |
Simultaneous online SPE-HPLC-MS/MS analysis of docetaxel, temsirolimus and sirolimus in whole blood and human plasma.
Topics: Antineoplastic Agents; Chromatography, High Pressure Liquid; Docetaxel; Humans; Sensitivity and Specificity; Sirolimus; Solid Phase Extraction; Tandem Mass Spectrometry; Taxoids | 2013 |
Quantification of cabazitaxel, its metabolite docetaxel and the determination of the demethylated metabolites RPR112698 and RPR123142 as docetaxel equivalents in human plasma by liquid chromatography-tandem mass spectrometry.
Topics: Chromatography, Liquid; Docetaxel; Drug Stability; Humans; Least-Squares Analysis; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry; Taxoids | 2013 |
Rapid and sensitive liquid chromatography coupled with electrospray ionization tandem mass spectrometry method for the analysis of paclitaxel, docetaxel, vinblastine, and vinorelbine in human plasma.
Topics: Antineoplastic Agents; Calibration; Carcinoma, Non-Small-Cell Lung; Chromatography, High Pressure Liquid; Docetaxel; Dose-Response Relationship, Drug; Drug Monitoring; Female; Humans; Lung Neoplasms; Male; Paclitaxel; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Taxoids; Vinblastine; Vinorelbine | 2014 |
Changes in primary breast cancer heterogeneity may augment midtreatment MR imaging assessment of response to neoadjuvant chemotherapy.
Topics: Adult; Aged; Anthracyclines; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Contrast Media; Docetaxel; Female; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Middle Aged; Neoadjuvant Therapy; Retrospective Studies; Sensitivity and Specificity; Software; Subtraction Technique; Taxoids; Trastuzumab; Treatment Outcome | 2014 |
Accurate sequential detection of primary tumor and metastatic lymphatics using a temperature-induced phase transition nanoparticulate system.
Topics: Animals; Antineoplastic Agents; Cattle; Docetaxel; Heating; Lymph Nodes; Lymphatic Metastasis; Male; Mice, Inbred BALB C; Mice, Nude; Nanoconjugates; Nanoparticles; Neoplasms, Experimental; Phase Transition; Poloxamer; Reproducibility of Results; Sensitivity and Specificity; Taxoids; Treatment Outcome | 2014 |
Development and validation of an ultrafiltration-UPLC-MS/MS method for rapid quantification of unbound docetaxel in human plasma.
Topics: Chromatography, High Pressure Liquid; Docetaxel; Drug Stability; Humans; Linear Models; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry; Taxoids; Ultrafiltration | 2014 |
ATP-based chemotherapy response assay in primary or recurrent ovarian and peritoneal cancer.
Topics: Adenocarcinoma, Clear Cell; Adenosine Triphosphate; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Carcinoma, Ovarian Epithelial; Cisplatin; Docetaxel; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Humans; Ifosfamide; Irinotecan; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Paclitaxel; Peritoneal Neoplasms; Predictive Value of Tests; Sensitivity and Specificity; Taxoids | 2014 |
Circulating tumor cells as a biomarker predictive of sensitivity to docetaxel chemotherapy in patients with castration-resistant prostate cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Biomarkers, Tumor; Bone Neoplasms; Disease Progression; Docetaxel; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Staging; Neoplastic Cells, Circulating; Prognosis; Prospective Studies; Prostatic Neoplasms, Castration-Resistant; Sensitivity and Specificity; Survival Rate; Taxoids | 2014 |
Molecular imaging of tumor-infiltrating macrophages in a preclinical mouse model of breast cancer.
Topics: Animals; Antineoplastic Agents; Cell Line; Cell Line, Tumor; Diphosphonates; Docetaxel; Female; Imidazoles; Lectins, C-Type; Lung Neoplasms; Macrophages; Mammary Neoplasms, Experimental; Mannose Receptor; Mannose-Binding Lectins; Mice; Mice, Inbred BALB C; Receptors, Cell Surface; Sensitivity and Specificity; Spectroscopy, Near-Infrared; Taxoids; Zoledronic Acid | 2015 |
Response evaluation after primary systemic therapy of Her2 positive breast cancer – an observational cross-sectional study.
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Cross-Sectional Studies; Docetaxel; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Receptor, ErbB-2; Sensitivity and Specificity; Taxoids; Tomography, X-Ray Computed; Trastuzumab | 2015 |
Serum diamine oxidase activity as a predictor of gastrointestinal toxicity and malnutrition due to anticancer drugs.
Topics: Adult; Aged; Amine Oxidase (Copper-Containing); Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Cisplatin; Docetaxel; Drug Combinations; Duodenum; Female; Gastrointestinal Diseases; Humans; Intestinal Mucosa; Male; Malnutrition; Middle Aged; Oxonic Acid; Prospective Studies; Sensitivity and Specificity; Stomach Neoplasms; Taxoids; Tegafur | 2015 |
New biomarkers for early detection of cardiotoxicity after treatment with docetaxel, doxorubicin and cyclophosphamide.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Biomarkers; Breast Neoplasms; Cardiotoxicity; Cardiovascular Diseases; Cyclophosphamide; Docetaxel; Doxorubicin; Echocardiography; Electroencephalography; Enzyme-Linked Immunosorbent Assay; Female; Galectin 3; Heart; Humans; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Sensitivity and Specificity; Taxoids; Tumor Necrosis Factor-alpha; Young Adult | 2015 |
Squamous Cell Carcinoma of the Head and Neck: Comparison of Diffusion-weighted MRI at b-values of 1,000 and 2,000 s/mm(2) to Predict Response to Induction Chemotherapy.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cetuximab; Cisplatin; Diffusion Magnetic Resonance Imaging; Docetaxel; Female; Fluorouracil; Forecasting; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Induction Chemotherapy; Male; Middle Aged; Mouth Neoplasms; Neoadjuvant Therapy; Neoplasm Staging; Pharyngeal Neoplasms; Remission Induction; Retrospective Studies; Sensitivity and Specificity; Taxoids; Tumor Burden | 2015 |
A Rapid and Sensitive UPLC-MS/MS Method for Determination of Docetaxel in Rabbit Plasma: Pharmacokinetic Study of New Lung-Targeting Docetaxel Liposome at Low Dose.
Topics: Animals; Antineoplastic Agents; Chromatography, Liquid; Docetaxel; Liposomes; Lung; Mass Spectrometry; Rabbits; Sensitivity and Specificity; Taxoids; Tissue Distribution | 2015 |
Determination of a hydrophilic paclitaxel derivative, 7-xylosyl-10-deacetylpaclitaxel in rat plasma by LC-MS/MS.
Topics: Animals; Chromatography, High Pressure Liquid; Docetaxel; Female; Paclitaxel; Rats; Rats, Wistar; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Taxoids; Time Factors | 2009 |
Sentinel lymph node biopsy after preoperative chemotherapy for breast cancer: findings from the Austrian Sentinel Node Study Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Austria; Breast Neoplasms; Cyclophosphamide; Docetaxel; Doxorubicin; Female; Fluorouracil; Humans; Lymph Node Excision; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Neoadjuvant Therapy; Preoperative Care; Retrospective Studies; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Taxoids | 2008 |
Cost-minimisation analysis of erlotinib in the second-line treatment of non-small-cell lung cancer: a Brazilian perspective.
Topics: Antineoplastic Agents; Brazil; Carcinoma, Non-Small-Cell Lung; Clinical Trials, Phase III as Topic; Cost Control; Disease-Free Survival; Docetaxel; Erlotinib Hydrochloride; Glutamates; Guanine; Humans; Lung Neoplasms; Pemetrexed; Quinazolines; Sensitivity and Specificity; Taxoids | 2008 |
What does similarity mean in clinical trials?
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Clinical Trials, Phase III as Topic; Deoxycytidine; Disease-Free Survival; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluorouracil; Gemcitabine; Humans; Prognosis; Risk Assessment; Sensitivity and Specificity; Survival Analysis; Taxoids | 2009 |
Simultaneous determination of anthracyclines and taxanes in human serum using online sample extraction coupled to high performance liquid chromatography with UV detection.
Topics: Anthracyclines; Antineoplastic Agents; Blood Proteins; Calibration; Chemistry, Pharmaceutical; Chromatography; Chromatography, High Pressure Liquid; Daunorubicin; Docetaxel; Doxorubicin; Epirubicin; Humans; Paclitaxel; Sensitivity and Specificity; Taxoids | 2010 |
Development and validation of a nylon6 nanofibers mat-based SPE coupled with HPLC method for the determination of docetaxel in rabbit plasma and its application to the relative bioavailability study.
Topics: Animals; Area Under Curve; Biological Availability; Caprolactam; Chromatography, High Pressure Liquid; Docetaxel; Drug Stability; Female; Least-Squares Analysis; Male; Nanofibers; Paclitaxel; Polymers; Rabbits; Reproducibility of Results; Sensitivity and Specificity; Solid Phase Extraction; Taxoids | 2010 |
Competitive mass spectrometry binding assay for characterization of three binding sites of tubulin.
Topics: Animals; Binding Sites; Binding, Competitive; Cattle; Chromatography, Liquid; Colchicine; Docetaxel; Guanosine Triphosphate; Linear Models; Paclitaxel; Podophyllotoxin; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry; Taxoids; Thiazoles; Tubulin; Tubulin Modulators; Vinblastine; Vincristine | 2010 |
Application of validated RP-HPLC method for simultaneous determination of docetaxel and ketoconazole in solid lipid nanoparticles.
Topics: Chromatography, High Pressure Liquid; Chromatography, Reverse-Phase; Docetaxel; Drug Delivery Systems; Drug Stability; Ketoconazole; Least-Squares Analysis; Lipids; Nanoparticles; Reproducibility of Results; Sensitivity and Specificity; Taxoids | 2011 |
[Early prediction of treatment response by serum CRP levels in patients with advanced esophageal cancer who underwent definitive chemoradiotherapy].
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Biomarkers; C-Reactive Protein; Carcinoma, Squamous Cell; Combined Modality Therapy; Disease Progression; Docetaxel; Esophageal Neoplasms; Female; Humans; Male; Middle Aged; Retrospective Studies; Sensitivity and Specificity; Taxoids; Treatment Outcome | 2010 |
MicroRNA expression profiles of head and neck squamous cell carcinoma with docetaxel-induced multidrug resistance.
Topics: Antineoplastic Agents; Carcinoma; Carcinoma, Squamous Cell; Cell Line, Tumor; Docetaxel; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; MicroRNAs; Neoplasms, Squamous Cell; Pharmacogenetics; Reverse Transcriptase Polymerase Chain Reaction; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Taxoids | 2011 |
Epidermal growth factor receptor mutations are associated with docetaxel sensitivity in lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Squamous Cell; Cisplatin; Deoxycytidine; DNA Mutational Analysis; DNA, Neoplasm; Docetaxel; Drug Resistance, Neoplasm; ErbB Receptors; Female; Follow-Up Studies; Gemcitabine; Humans; Lung Neoplasms; Male; Middle Aged; Mutation; Neoplasm Staging; Polymerase Chain Reaction; Sensitivity and Specificity; Survival Rate; Taxoids; Treatment Outcome; Tumor Cells, Cultured; Vinblastine; Vinorelbine | 2011 |
A sensitive combined assay for the quantification of paclitaxel, docetaxel and ritonavir in human plasma using liquid chromatography coupled with tandem mass spectrometry.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chromatography, High Pressure Liquid; Docetaxel; Humans; Neoplasms; Paclitaxel; Ritonavir; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Taxoids | 2011 |
Adding docetaxel to cisplatin and fluorouracil in patients with unresectable head and neck cancer: a cost-utility analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Cost-Benefit Analysis; Decision Support Techniques; Docetaxel; Fluorouracil; Head and Neck Neoplasms; Induction Chemotherapy; Markov Chains; Monte Carlo Method; Randomized Controlled Trials as Topic; Sensitivity and Specificity; Survival Analysis; Taxoids | 2012 |
A rapid and sensitive LC/ESI-MS/MS method for quantitative analysis of docetaxel in human plasma and its application to a pharmacokinetic study.
Topics: Chromatography, Liquid; Docetaxel; Drug Stability; Head and Neck Neoplasms; Humans; Linear Models; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry; Taxoids | 2012 |
Determination of docetaxel in rat plasma and its application in the comparative pharmacokinetics of Taxotere and SID530, a novel docetaxel formulation with hydroxypropyl-β-cyclodextrin.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; Area Under Curve; beta-Cyclodextrins; Chromatography, Liquid; Docetaxel; Male; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry; Taxoids | 2013 |
Does androgen-ablation therapy (AAT) associated autophagy have a pro-survival effect in LNCaP human prostate cancer cells?
Topics: Androgen Antagonists; Anilides; Antineoplastic Combined Chemotherapy Protocols; Autophagy; Blotting, Western; Cell Line, Tumor; Cell Survival; Docetaxel; Flow Cytometry; Humans; Immunohistochemistry; Male; Microscopy, Confocal; Nitriles; Prostatic Neoplasms; RNA, Small Interfering; Sensitivity and Specificity; Taxoids; Tosyl Compounds | 2013 |
[[¹¹C]choline as a pharmacodynamic marker for docetaxel therapy. Response assessment in a LNCaP prostate cancer xenograft mouse model].
Topics: Animals; Antineoplastic Agents; Carbon Radioisotopes; Cell Line, Tumor; Choline; Docetaxel; Male; Mice; Mice, SCID; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Taxoids; Treatment Outcome | 2013 |
In vitro comparative evaluation of trastuzumab (Herceptin) combined with paclitaxel (Taxol) or docetaxel (Taxotere) in HER2-expressing human breast cancer cell lines.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Docetaxel; Dose-Response Relationship, Drug; Female; Flow Cytometry; Gene Expression Regulation; Genes, erbB-2; Humans; Immunohistochemistry; Paclitaxel; Probability; Sensitivity and Specificity; Statistics, Nonparametric; Taxoids; Trastuzumab; Tumor Cells, Cultured | 2002 |
Sensitive liquid chromatography-mass spectrometry assay for quantitation of docetaxel and paclitaxel in human plasma.
Topics: Antineoplastic Agents, Phytogenic; Chromatography, High Pressure Liquid; Docetaxel; Humans; Paclitaxel; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Taxoids | 2003 |
Microtubule-associated parameters as predictive markers of docetaxel activity in advanced breast cancer patients: results of a pilot study.
Topics: Adult; Aged; Biomarkers, Tumor; Biopsy, Needle; Bone Neoplasms; Breast Neoplasms; Disease Progression; Docetaxel; Dose-Response Relationship, Drug; Female; Humans; Immunohistochemistry; Microtubules; Middle Aged; Neoplasm Invasiveness; Paclitaxel; Pilot Projects; Predictive Value of Tests; Prognosis; Sensitivity and Specificity; Soft Tissue Neoplasms; Survival Analysis; tau Proteins; Taxoids; Treatment Outcome; Tubulin | 2002 |
Simultaneous analysis of docetaxel and the formulation vehicle polysorbate 80 in human plasma by liquid chromatography/tandem mass spectrometry.
Topics: Chromatography, High Pressure Liquid; Docetaxel; Drug Carriers; Drug Monitoring; Humans; Mass Spectrometry; Polysorbates; Reproducibility of Results; Sensitivity and Specificity; Taxoids | 2004 |
Simple and rapid docetaxel assay in plasma by protein precipitation and high-performance liquid chromatography-tandem mass spectrometry.
Topics: Animals; Antineoplastic Agents, Phytogenic; Chromatography, High Pressure Liquid; Docetaxel; Female; Mass Spectrometry; Mice; Proteins; Reproducibility of Results; Sensitivity and Specificity; Taxoids | 2004 |
Enhancement of radiation effects by combined docetaxel and flavopiridol treatment in lung cancer cells.
Topics: Animals; Cell Survival; Combined Modality Therapy; Disease Models, Animal; Docetaxel; Drug Therapy, Combination; Female; Flavonoids; Humans; In Vitro Techniques; Lung Neoplasms; Mice; Mice, Nude; Neoplasm Transplantation; Piperidines; Probability; Radiation Dosage; Radiation-Sensitizing Agents; Sensitivity and Specificity; Survival Rate; Taxoids; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2004 |
Enhanced method performance due to a shorter chromatographic run-time in a liquid chromatography-tandem mass spectrometry assay for paclitaxel.
Topics: Antineoplastic Agents, Phytogenic; Atmospheric Pressure; Chromatography, High Pressure Liquid; Docetaxel; Humans; Mass Spectrometry; Paclitaxel; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Taxoids | 2004 |
Effects of paclitaxel and docetaxel on EGFR-expressing human carcinoma cells under normoxic versus hypoxic conditions in vitro.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle; Cell Survival; Docetaxel; Drug Resistance, Neoplasm; ErbB Receptors; Female; Humans; Hypoxia; Male; Neoplasms; Paclitaxel; Probability; Reference Values; Sensitivity and Specificity; Taxoids; Tumor Cells, Cultured | 2004 |
Rapid analysis of docetaxel in human plasma by tandem mass spectrometry with on-line sample extraction.
Topics: Calibration; Docetaxel; Humans; Reproducibility of Results; Sensitivity and Specificity; Specimen Handling; Spectrometry, Mass, Electrospray Ionization; Taxoids; Time Factors | 2004 |
Quantitative analysis of docetaxel in human plasma using liquid chromatography coupled with tandem mass spectrometry.
Topics: Administration, Oral; Antineoplastic Agents, Phytogenic; Chromatography, Liquid; Docetaxel; Drug Stability; Humans; Mass Spectrometry; Reproducibility of Results; Sensitivity and Specificity; Taxoids | 2005 |
A molecular model to explain paclitaxel and docetaxel sensitivity changes through adduct formation with primary amines in electrospray ionization mass spectrometry.
Topics: Amines; Chromatography, Liquid; Docetaxel; Models, Chemical; Models, Molecular; Molecular Structure; Paclitaxel; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Taxoids | 2005 |
Development and validation of a liquid chromatography-tandem mass spectrometry assay for the quantification of docetaxel and paclitaxel in human plasma and oral fluid.
Topics: Antineoplastic Agents; Chromatography, Liquid; Docetaxel; Drug Stability; Humans; Molecular Structure; Paclitaxel; Reproducibility of Results; Saliva; Sensitivity and Specificity; Tandem Mass Spectrometry; Taxoids | 2005 |
Quantification of docetaxel and its main metabolites in human plasma by liquid chromatography/tandem mass spectrometry.
Topics: Antineoplastic Agents; Calibration; Chromatography, Liquid; Docetaxel; Humans; Injections, Intravenous; Molecular Structure; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Taxoids | 2005 |
Clinical and radiologic assessments to predict breast cancer pathologic complete response to neoadjuvant chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Diagnostic Imaging; Docetaxel; Doxorubicin; Female; Humans; Magnetic Resonance Imaging; Mammography; Middle Aged; Neoadjuvant Therapy; Neoplasm, Residual; Palpation; Predictive Value of Tests; Sensitivity and Specificity; Taxoids; Ultrasonography, Mammary | 2005 |
The effect of alkylamine additives on the sensitivity of detection for paclitaxel and docetaxel and analysis in plasma of paclitaxel by liquid chromatography-tandem mass spectrometry.
Topics: Amines; Chromatography, Liquid; Docetaxel; Mass Spectrometry; Paclitaxel; Reproducibility of Results; Sensitivity and Specificity; Taxoids | 2006 |
High sensitivity assays for docetaxel and paclitaxel in plasma using solid-phase extraction and high-performance liquid chromatography with UV detection.
Topics: Antineoplastic Agents; Chromatography, High Pressure Liquid; Docetaxel; Humans; Paclitaxel; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Taxoids | 2006 |
Gene expression signature predicting pathologic complete response with gemcitabine, epirubicin, and docetaxel in primary breast cancer.
Topics: Adult; Aged; Algorithms; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Deoxycytidine; Docetaxel; Epirubicin; Female; Gemcitabine; Gene Expression Profiling; Humans; Immunohistochemistry; Middle Aged; Multivariate Analysis; Predictive Value of Tests; Sensitivity and Specificity; Taxoids; Treatment Outcome | 2006 |
Preclinical characterization of AEG35156/GEM 640, a second-generation antisense oligonucleotide targeting X-linked inhibitor of apoptosis.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Disease Models, Animal; Docetaxel; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Drug Synergism; Gene Expression Profiling; Humans; Mice; Mice, Nude; Neoplasms; Oligodeoxyribonucleotides, Antisense; Oligonucleotides; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sensitivity and Specificity; Structure-Activity Relationship; Taxoids; TNF-Related Apoptosis-Inducing Ligand; Transplantation, Heterologous; X-Linked Inhibitor of Apoptosis Protein; Xenograft Model Antitumor Assays | 2006 |
Novel C2-C3' N-peptide linked macrocyclic taxoids. Part 2: synthesis and biological activities of docetaxel analogues with a peptide side chain at C2 and their macrocyclic derivatives.
Topics: Antineoplastic Agents; Binding Sites; Cell Line, Tumor; Cell Proliferation; Computational Biology; Crystallography, X-Ray; Docetaxel; Drug Screening Assays, Antitumor; Humans; Macrocyclic Compounds; Models, Molecular; Molecular Conformation; Peptides; Protein Structure, Secondary; Sensitivity and Specificity; Stereoisomerism; Structure-Activity Relationship; Taxoids | 2007 |
Response to neoadjuvant chemotherapy in breast cancer could be predictable by measuring a novel serum apoptosis product, caspase-cleaved cytokeratin 18: a prospective pilot study.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Docetaxel; Epirubicin; Female; Fluorouracil; Humans; Immunoenzyme Techniques; Keratin-18; Middle Aged; Neoadjuvant Therapy; Pilot Projects; Predictive Value of Tests; Prospective Studies; Sensitivity and Specificity; Taxoids; Treatment Outcome | 2006 |
Chemotherapy resistance and oncogene expression in non-small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy, Needle; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deoxycytidine; Docetaxel; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Flow Cytometry; Gemcitabine; Humans; Lung Neoplasms; Male; Oncogenes; Ploidies; Probability; Sensitivity and Specificity; Taxoids; Treatment Outcome; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Vinblastine | 2007 |
Role of intercellular communications in breast cancer multicellular tumor spheroids after chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Communication; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Combined Modality Therapy; Connexin 43; Docetaxel; Doxorubicin; Female; Humans; Immunohistochemistry; Membrane Proteins; Microscopy, Electron, Scanning Transmission; Models, Biological; Occludin; Sensitivity and Specificity; Spheroids, Cellular; Structure-Activity Relationship; Taxoids; Tumor Cells, Cultured | 2006 |
Translation, please.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Docetaxel; Epirubicin; Female; Fluorouracil; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genetic Testing; Humans; Neoadjuvant Therapy; Neoplasm Staging; Oligonucleotide Array Sequence Analysis; Patient Selection; Predictive Value of Tests; Receptors, Estrogen; Reproducibility of Results; Research Design; Sensitivity and Specificity; Taxoids; Treatment Outcome | 2007 |
Experimental antitumor activity and pharmacokinetics of the camptothecin analog irinotecan (CPT-11) in mice.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Camptothecin; Docetaxel; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Humans; Irinotecan; Leukemia, Experimental; Male; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Paclitaxel; Sensitivity and Specificity; Taxoids; Vincristine | 1996 |
Determination of paclitaxel in biological fluids by micellar electrokinetic chromatography.
Topics: Acetonitriles; Antineoplastic Agents, Phytogenic; Docetaxel; Electrophoresis, Capillary; Humans; Linear Models; Micelles; Paclitaxel; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Sodium Dodecyl Sulfate; Taxoids | 1996 |
Pre-clinical evaluation of new antineoplastic agents in NSCLC cell lines: evidence of histological subtype-dependent cytotoxicity.
Topics: Adenocarcinoma; Antineoplastic Agents; Camptothecin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cell Division; Cell Survival; Cisplatin; Deoxycytidine; Docetaxel; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Gemcitabine; Humans; Inhibitory Concentration 50; Irinotecan; Lung Neoplasms; Paclitaxel; Sensitivity and Specificity; Taxoids; Topoisomerase I Inhibitors; Topotecan; Tumor Cells, Cultured | 1999 |
Liquid chromatographic analysis and preliminary pharmacokinetics of methotrexate in cancer patients co-treated with docetaxel.
Topics: Acetone; Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Chemical Precipitation; Chromatography, High Pressure Liquid; Docetaxel; Humans; Hydroxylation; Kinetics; Methanol; Methotrexate; Neoplasms; Paclitaxel; Rats; Rats, Wistar; Sensitivity and Specificity; Taxoids | 1999 |
Positron emission tomography using [(18)F]-fluorodeoxy-D-glucose to predict the pathologic response of breast cancer to primary chemotherapy.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Axilla; Biopsy; Breast Neoplasms; Cyclophosphamide; Docetaxel; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Paclitaxel; Prednisolone; Radiopharmaceuticals; Sensitivity and Specificity; Taxoids; Tomography, Emission-Computed; Vincristine | 2000 |
Rapid high-performance liquid chromatographic determination of docetaxel (Taxotere) in plasma using liquid-liquid extraction.
Topics: Antineoplastic Agents, Phytogenic; Chromatography, High Pressure Liquid; Docetaxel; Humans; Paclitaxel; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Taxoids | 2001 |
Cost-minimisation analysis of three regimens of chemotherapy (docetaxel-cisplatin, paclitaxel-cisplatin, paclitaxel-carboplatin) for advanced non-small-cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Cost-Benefit Analysis; Docetaxel; Drug Costs; Economics, Pharmaceutical; Humans; Infusions, Intravenous; Lung Neoplasms; Neoplasm Staging; Paclitaxel; Sensitivity and Specificity; Survival Rate; Taxoids | 2002 |
Economic analysis of the TAX 317 trial: docetaxel versus best supportive care as second-line therapy of advanced non-small-cell lung cancer.
Topics: Antineoplastic Agents, Phytogenic; Canada; Carcinoma, Non-Small-Cell Lung; Cost-Benefit Analysis; Costs and Cost Analysis; Docetaxel; Hospitalization; Humans; Lung Neoplasms; Paclitaxel; Palliative Care; Radiotherapy; Retrospective Studies; Sensitivity and Specificity; Taxoids | 2002 |
Determination of the docetaxel vehicle, polysorbate 80, in patient samples by liquid chromatography-tandem mass spectrometry.
Topics: Antineoplastic Agents, Phytogenic; Calibration; Docetaxel; Humans; Neoplasms; Paclitaxel; Pharmaceutical Vehicles; Polysorbates; Reproducibility of Results; Sensitivity and Specificity; Taxoids | 2002 |